IP Library Assignment 030789/0942
Patent Assignment
Reel/Frame 030789/0942

Change of Name

Recorded: 2013-07-11 Pages: 2
Assignor
NEURON SYSTEMS, INC.
Executed: 2012-12-20
Assignee
ALDEXA THERAPEUTICS, INC.
15 NEW ENGLAND EXECUTIVE PARK, BURLINGTON, MASSACHUSETTS, 01803
Covered Property (1)
Compositions and methods of treating retinal disease
Patent: 8,940,764 →
Application: 11/920,866 →
Publication: US 2009/0182009
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 26, 2009
From: JORDAN, THOMAS A.; DOWLING, JOHN E.; CHABALA, JOHN CLIFFORD
To: NEURON SYSTEMS, INC.
Reel/Frame 022154/0893 →
Change of Address of Assignee May 11, 2010
From: JORDAN, THOMAS A.; DOWLING, JOHN E.; CHABALA, JOHN CLIFFORD
To: NEURON SYSTEMS, INC.
Reel/Frame 024367/0649 →
Security Agreement Apr 24, 2012
From: NEURON SYSTEMS, INC
To: SQUARE 1 BANK
Reel/Frame 028095/0947 →
Change of Name Oct 15, 2015
From: ALDEXA THERAPEUTICS, INC.
To: ALDEYRA THERAPEUTICS, INC.
Reel/Frame 036867/0900 →
Release of Security Interest Dec 5, 2018
From: PACIFIC WESTERN BANK (SUCCESSOR BY MERGER TO SQUARE 1 BANK)
To: ALDEYRA THERAPEUTICS, INC. (F/K/A ALDEXA THERAPEUTICS, INC. F/K/A NEURON SYSTEMS, INC.)
Reel/Frame 047683/0482 →